Kerin B. Adelson
- Oncology top 5%
- Public Health, Environmental and Occupational Health top 2%
- Pediatrics, Perinatology and Child Health top 5%
- Pulmonary and Respiratory Medicine top 10%
- Economics and Econometrics top 5%
- Co-authors
- Cary P. GrossM. Elizabeth PaulkAlfred I. NeugutManish A. ShahYuhua BaoPaul K. MaciejewskiHolly G. PrigersonBryan J. Schneider
- Topics
- Palliative Care and End-of-Life Issues (35 papers)Economic and Financial Impacts of Cancer (24 papers)Health Systems, Economic Evaluations, Quality of Life (14 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
Kerin B. Adelson
83 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 804
- Public Health, Environmental and Occupational Health 717
- Pediatrics, Perinatology and Child Health 346
- Pulmonary and Respiratory Medicine 308
- Economics and Econometrics 226
Countries citing papers authored by Kerin B. Adelson
This map shows the geographic impact of Kerin B. Adelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerin B. Adelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerin B. Adelson more than expected).
Fields of papers citing papers by Kerin B. Adelson
This network shows the impact of papers produced by Kerin B. Adelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerin B. Adelson. The network helps show where Kerin B. Adelson may publish in the future.
Co-authorship network of co-authors of Kerin B. Adelson
This figure shows the co-authorship network connecting the top 25 collaborators of Kerin B. Adelson. A scholar is included among the top collaborators of Kerin B. Adelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerin B. Adelson. Kerin B. Adelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 12 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 0 | |
| 9 | 13 | |
| 10 | 2 | |
| 11 | 92 | |
| 12 | 21 | |
| 13 | 9 | |
| 14 | 14 | |
| 15 | 3 | |
| 16 | 17 | |
| 17 | 9 | |
| 18 | 63 | |
| 19 | A phase II trial of neoadjuvant aromatase inhibitor therapy and the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and a low/intermediate risk Oncotype Dx Recurrence Score (≤ 25). | 1 |
| 20 | 6 |
About Kerin B. Adelson
Kerin B. Adelson is a scholar working on Geriatrics and Gerontology, Oncology and Public Health, Environmental and Occupational Health, having authored 86 papers that have together received 1.6k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (35 papers), Economic and Financial Impacts of Cancer (24 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). The work is most often cited by research in Oncology (804 citations), Public Health, Environmental and Occupational Health (717 citations) and Geriatrics and Gerontology (73 citations). Kerin B. Adelson has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Cary P. Gross, M. Elizabeth Paulk, Alfred I. Neugut, Manish A. Shah, Yuhua Bao, Paul K. Maciejewski, Holly G. Prigerson, Bryan J. Schneider, M. Carrington Reid and Melissa M. Garrido. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.